Viking Therapeutics, Inc. - Common Stock (VKTX)
CUSIP: 92686J106
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 115,694,154
- Total 13F shares
- 9,329,591
- Share change
- +7,061,082
- Total reported value
- $37,876,000
- Price per share
- $4.06
- Number of holders
- 32
- Value change
- +$30,074,098
- Number of buys
- 28
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 92686J106?
CUSIP 92686J106 identifies VKTX - Viking Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92686J106:
Top shareholders of VKTX - Viking Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ASCEND CAPITAL, LLC |
13F
|
Company |
0.42%
|
488,208
|
$932,000 | — | 30 Sep 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.35%
|
402,600
|
$769,000 | — | 30 Sep 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.29%
|
338,789
|
$647,000 | — | 30 Sep 2017 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.25%
|
290,000
|
$554,000 | — | 30 Sep 2017 | |
| Park West Asset Management LLC |
13F
|
Company |
0.17%
|
200,000
|
$382,000 | — | 30 Sep 2017 | |
| SHEPHERD KAPLAN KROCHUK, LLC |
13F
|
Company |
0.07%
|
75,570
|
$136,000 | — | 30 Sep 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
56,461
|
$108,000 | — | 30 Sep 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
51,247
|
$98,000 | — | 30 Sep 2017 | |
| Virtu Financial LLC |
13F
|
Company |
0.03%
|
36,588
|
$70,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
31,264
|
$59,000 | — | 30 Sep 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
16,962
|
$32,000 | — | 30 Sep 2017 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.01%
|
11,481
|
$22,000 | — | 30 Sep 2017 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.01%
|
10,366
|
$20,000 | — | 30 Sep 2017 | |
| Creative Planning |
13F
|
Company |
0.01%
|
10,000
|
$19,000 | — | 30 Sep 2017 | |
| REILLY FINANCIAL ADVISORS, LLC |
13F
|
Company |
0%
|
1,250
|
$2,000 | — | 30 Sep 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
703
|
$1,000 | — | 30 Sep 2017 | |
| Advisor Group, Inc. |
13F
|
Company |
0%
|
500
|
$1,000 | — | 30 Sep 2017 |
Institutional Holders of Viking Therapeutics, Inc. - Common Stock (VKTX) as of Q4 2017
As of 31 Dec 2017,
Viking Therapeutics, Inc. - Common Stock (VKTX) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,329,591 shares.
The largest 10 holders included
SPHERA FUNDS MANAGEMENT LTD., Sio Capital Management, LLC, Vanguard Group Inc, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, Park West Asset Management LLC, Opaleye Management Inc., PURA VIDA INVESTMENTS, LLC, EAM Investors, LLC, and EAM Global Investors LLC.
This page lists
32
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
16
Q4 2017 holders
32
Holder diff
16
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.